Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Aerie Pharmaceuticals Company Profile (NASDAQ:AERI)

Consensus Ratings for Aerie Pharmaceuticals (NASDAQ:AERI) (?)
Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $26.43 (142.02% upside)

Analysts' Ratings History for Aerie Pharmaceuticals (NASDAQ:AERI)
Show:
DateFirmActionRatingPrice TargetActions
5/8/2015Cantor FitzgeraldUpgradeHold -> Buy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015ZacksUpgradeSell -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Stifel NicolausLower Price TargetBuy$40.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015RBC CapitalLower Price TargetOutperform$50.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Canaccord GenuityDowngradeBuy -> Hold$40.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Cantor FitzgeraldDowngradeBuy -> Hold$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Brean CapitalLower Price TargetBuy$46.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015RBC CapitalBoost Price TargetOutperform$45.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015Cantor FitzgeraldReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015MLV & Co.Reiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015Brean CapitalInitiated CoverageBuy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Canaccord GenuityReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015MLV & Co.Reiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Cantor FitzgeraldInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2014RBC CapitalBoost Price TargetOutperform$36.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/3/2014Canaccord GenuityInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2014RBC CapitalBoost Price TargetOutperform$27.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2014Needham & Company LLCBoost Price TargetBuy$26.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2014RBC CapitalLower Price TargetOutperform$28.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Stifel NicolausBoost Price TargetPositive -> Buy$22.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014RBC CapitalBoost Price TargetOutperform$25.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Needham & Company LLCBoost Price TargetBuy$22.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013Needham & Company LLCInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013Canaccord GenuityInitiated CoverageBuy -> Buy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013RBC CapitalInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013Stifel NicolausInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/23/2013 forward)